Filing Details

Accession Number:
0001209191-11-054808
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-11-07 18:16:14
Reporting Period:
2011-11-01
Filing Date:
2011-11-07
Accepted Time:
2011-11-07 18:16:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1301081 Pharmasset Inc VRUS Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1284621 J. Michael Otto 303A College Road East
Princeton NJ 08540
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-11-01 17,500 $10.83 17,500 No 4 M Direct
Common Stock Disposition 2011-11-01 17,500 $74.56 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2011-11-01 17,500 $0.00 17,500 $10.83
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-10-14 No 4 M Direct
Footnotes
  1. This transaction is the result of standing instructions set forth in a Rule 10b5-1 plan previously established by filer.
  2. The number of shares beneficially owned reflected in Items 5 and 9 of this Form 4 represent a two-for-one stock split (the "Split") of the Issuer's common stock which is structured in the form of a dividened payable on August 31, 2011 to the stockholders of record at the close of business August 22, 2011.
  3. A total of 20,000 pre-Split (40,000 post-Split) options were granted on 10/14/2009. Shares vest on the following schedule: 25% on the first anniversary of the grant, and 6.25% quarterly thereafter.